You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Apotex Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?

APOTEX INC has one hundred and five approved drugs.

There are thirteen tentative approvals on APOTEX INC drugs.

Summary for Apotex Inc

US Patents:	0
Tradenames:	83
Ingredients:	80
NDAs:	105
Drug Master File Entries:	2
Patent Litigation for Apotex Inc:	See patent lawsuits for Apotex Inc
PTAB Cases with Apotex Inc as petitioner:	See PTAB cases with Apotex Inc as petitioner

Drugs and US Patents for Apotex Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex Inc	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING;ORAL	202477-002	Jul 1, 2013		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Apotex Inc	ALPRAZOLAM	alprazolam	TABLET;ORAL	077741-004	Jan 19, 2007	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Apotex Inc	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	076795-001	Nov 22, 2004		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Apotex Inc	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	202244-002	Dec 31, 2012		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.